Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 46 (4) , 1124-1132
- https://doi.org/10.1038/ki.1994.375
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Early History of Renal RicketsAmerican Journal of Nephrology, 1993
- The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary HyperparathyroidismNephron, 1991
- Bone histomorphometric reference values in 88 normal Italian subjectsBone and Mineral, 1990
- Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysisKidney International, 1989
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Suppressive Effect of 1,25-Dihydroxyvitamin D3on Circulating Parathyroid Hormone in Acute Renal FailureJournal of Clinical Endocrinology & Metabolism, 1981
- 1,25 Dihydroxycholecalciferol Effects in Chronic DialysisAnnals of Internal Medicine, 1978